Thoracic and abdominal MRA with gadofosveset: Influence of injection rate on vessel signal and image quality

European Radiology

Volumn 19, Issue 8, 2009, Pages 1932-1938

  Nissen, Johanna C ^a   Attenberger, Ulrike I ^a   Fink, Christian ^a   Dietrich, Olaf ^b   Rohrer, Martin ^c   Schoenberg, Stefan O ^a   Michaely, Henrik J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

1.5 Tesla; Gadofosveset; Injection rate; Intravascular contrast agent; Time resolved MRA

Indexed keywords

GADOFOSVESET;

ABDOMEN; ABDOMINAL AORTA; ADULT; AORTA ARCH; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; INJECTION; KIDNEY PARENCHYMA; KIDNEY VEIN; LUNG PARENCHYMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; THORAX; VOLUNTEER;

ABDOMEN; ADULT; ARTERIES; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; INJECTIONS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THORAX;

EID: 67650898520     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1381-y     Document Type: Article

References (16)

1. Lauffer RB, Parmelee DJ, Dunham SU et al (1998) MS-325: Albumin-targeted contrast agent for MR angiography. Radiology 207:529-538
2. Rohrer M (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724
3. Caravan P, Parigi G, Chasse JM et al (2007) Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorg Chem 46:6632-6639
4. Klessen C, Hein PA, Huppertz A et al (2007) First-pass whole-body magnetic resonance angiography (mra) using the blood-pool contrast medium gadofosveset trisodium: Comparison to gadopentetate dimeglumine. Invest Radiol 42:659-664
5. Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M (2006) Initial imaging recommendations for Vasovist angiography. Eur Radiol 16(Suppl 2):B15-B23
6. Grist TM, Korosec FR, Peters DC et al (1998) Steady-state and dynamic MR angiography with MS-325: Initial experience in humans. Radiology 207:539-544
7. Hartmann M (2006) Initial imaging recommendations for Vasovist angiography. Eur Radiol 16(Suppl 2):B15-B23
8. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724
9. Caravan P, Cloutier NJ, Greenfield MT et al (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 124:3152-3162
10. Eldredge HB, Spiller M, Chasse JM, Greenwood MT, Caravan P (2006) Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Invest Radiol 41:229-243
11. Griswold MA, Jakob PM, Heidemann RM et al (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202-1210
12. Korosec FR, Frayne R, Grist TM, Mistretta CA (1996) Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36:345-351
13. Fink C, Ley S, Kroeker R et al (2005) Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 40:40-48
14. Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO (2007) Measurement of signal-to-noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 26:375-385
15. Fink C, Puderbach M, Ley S et al (2004) Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Invest Radiol 39:143-148
16. Johnson TR, Nikolaou K, Wintersperger BJ et al (2007) Optimization of contrast material administration for electrocardiogram-gated computed tomographic angiography of the chest. J Comput Assist Tomogr 31:265-271